# clm_3745B13B8F94

subject: Gilead Sciences (/record/gilead-sciences.md)  
predicate: quarterly_operating_income  
value: 1,705,000,000 United States dollar  
valid_from: 2023-03-31  
valid_to: 2023-06-30  
published: 2023-05-03  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_28DC5CDFDC6E  
last_updated: 2026-11-08  
cite: AsOf. "Gilead Sciences quarterly operating income: 1,705,000,000 United States dollar", as of 2023-03-31 (until 2023-06-30). Claim clm_3745B13B8F94, https://asof.is/claim/clm_3745B13B8F94, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209523000017/0000882095-23-000017-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2023, filed 2023-05-03  

## Sources

- https://www.sec.gov/Archives/edgar/data/882095/000088209523000017/0000882095-23-000017-index.htm (primary, SEC EDGAR 10-Q Q1 FY2023, published 2023-05-03)

## Supersedes

- [Gilead Sciences](/record/gilead-sciences.md) | quarterly_operating_income | 2,837,000,000 United States dollar | valid 2022-09-30 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_3745B13B8F94](/claim/clm_3745B13B8F94.md) | [clm_AFE437797FF5](/claim/clm_AFE437797FF5.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.